New Regulations in Australia to Control E-cigarette Access for Youth

Regulations by 2FIRSTS.ai
Jan.09.2024
New Regulations in Australia to Control E-cigarette Access for Youth
Australia's government recently released new regulations to address loopholes in the current laws on e-cigarette products.

According to a report by Lifehacker on January 9th, the Australian government has recently introduced a series of new regulations. These regulations aim to address existing legal loopholes and prevent easy access by teenagers to highly addictive, heavily flavored, inexpensive, and harmful e-cigarette products available in the market.

 

According to regulations prior to 2024, e-cigarette products imported and sold in Australia were required to be nicotine-free, unless obtained through a pharmacy with a prescription from a qualified healthcare professional. Individual users were also allowed to import nicotine-containing e-cigarettes through a personal importation scheme, provided they had a valid prescription.

 

The e-cigarette industry, which encompasses manufacturers, importers, and retailers, exploits these loopholes by falsely claiming that their products are "nicotine-free".

 

However, the only way to distinguish between e-cigarettes that contain nicotine and those that do not is through laboratory testing. Given the large quantity of imported products, this task is time-consuming and expensive, making it nearly impossible to implement a nicotine/non-nicotine standard.

 

The new regulations will help eliminate confusion and make the rules clearer and easier to enforce. It also addresses the issue of easy accessibility of e-cigarettes, which is the biggest challenge in preventing youth smoking.

 

The new regulations will be implemented in three stages.

 

Import Ban: The first phase of the import ban will be implemented from January 1, 2024, encompassing all disposable and single-use e-cigarettes. These products, which come in various flavors such as fruits, candies, cocktails, and tobacco, are particularly popular among young people. While disposable and single-use e-cigarettes cannot be refilled, they come in various sizes ranging from a few hundred puffs to over ten thousand puffs.

 

Starting from March 1, 2024, all other e-cigarettes, including refillable products, will be prohibited from importing unless the importers hold a license and permit from the Office of Drug Control. These legally imported e-cigarettes can only be sold in pharmacies and can only be purchased by users with a prescription.

 

The individual import scheme for e-cigarettes is set to expire on March 1, 2024, which means all e-cigarette users will be required to obtain their products from pharmacies in Australia. While this initial phase has effectively prevented illegal e-cigarettes from entering the country, it has not addressed the existing high volume of products. Retailers are still permitted to sell their existing "nicotine-free" e-cigarette inventory, although it is widely known that these products often do contain nicotine.

 

Ban on domestic manufacturing and sales: The next phase of the reform, expected to take effect later in 2024, will eliminate retail sales of all types of e-cigarette products, regardless of their claimed nicotine content. This second stage will include a prohibition on the manufacturing, supply, advertising, and commercial possession of e-cigarettes that exceed prescription framework limits.

 

These changes will require amendments to the 1989 Therapeutic Commodities Act, which is expected to be submitted for federal parliamentary review in the autumn of 2024, although the exact date has not yet been determined.

 

Prescription Access: Prescription access for e-cigarettes for therapeutic purposes is also undergoing changes, allowing access to products that meet quality standards. Starting from January 1, 2024, all medical and nursing professionals are now able to prescribe therapeutic e-cigarettes for smoking cessation or nicotine addiction management. It is expected that further modifications to the standards for therapeutic e-cigarettes will be made by March 1, 2024, including restrictions on nicotine content, permitted flavor types, and the adoption of standardized medical-style packaging.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
U.S. vape company Charlie’s Holdings announced plans to pilot its age-gated flavored disposable vape products in hundreds of retail stores during the third quarter of 2026. The company said the products will utilize AI- and blockchain-powered age-verification technology designed to address FDA concerns over youth access and potentially create a new compliance pathway for flavored vape products.
Jun.15
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.
Industry Insight
Jun.11
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
2Firsts supports new tobacco and nicotine companies entering the U.S. market with full-chain PMTA compliance services.
Jun.04